AzTrials
AzTrials

Spinal Cord InjuredRenfExcNCT06099340

Effects of an Eccentric Muscle Strengthening Protocol on Force Moment, Muscle Activation and Plantar Flexor Structure of Patients With Central Nervous System Injuries.

A study testing muscle-strengthening program in people with Spinal Cord Injured and Post-stroke, run by Nantes University Hospital at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Neurological disorders [such as Cerebral Vascular Accident (CVA) or Spinal Cord Injury (SCI)] are among the most costly health problems to society in industrialized countries. For those affected, they generate severe restrictions in mobility, significantly altering their quality of life. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Spinal Cord Injured, Post-stroke
What is being tested?
muscle-strengthening program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteFrance
Study dates
Sep 2024to Oct 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient aged between 18 and 80 years
  • Patient with stroke< 6 months or Patient with spinal cord injury American Spinal Injury Association (ASIA) Impairment Scale C or D (incomplete motor impairment) < 6 months (second secondary criterion).
  • Patient hospitalized for primary rehabilitation in the neurological PRM department of Nantes University Hospital.
  • Patient with voluntary motricity rated between 2 and 4 on the MRC (Medical Research Council) scale

Who cannot join

  • History of functional surgery <3 months or intramuscular injection into plantar flexors <6 months
  • Patient with osteoarticular lesions contraindicating rehabilitation
  • Patient unlikely to adhere to protocol (severe cognitive impairment) and/or non-compliant
  • Patient with a progressive pathology contraindicating efforts (syrinx, cancer, cardiovascular instability, etc.)
  • Minors, protected adults, adults unable to give consent or pregnant women.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Raphael Gross, PU-PH contact

02.40.84.62.08

raphael.gross@chu-nantes.fr

Guillaume Le Sant contact

guillaume.le-sant@univ-nantes.fr

France1 site
  • Chu de Nantes

    Nantes, 44400

    Raphael GROSS, 0240846208, raphael.gross@chu-nantes.fr

Other trials in France

About this study

Official title: Effects of an Eccentric Muscle Strengthening Protocol on Force Moment, Muscle Activation and Plantar Flexor Structure in Patients With Central Nervous System Injuries. A Randomized Controlled Trial in Post-stroke Patients and a Pilot Study in Spinal Cord Injured Patients.

Neurological disorders [such as Cerebral Vascular Accident (CVA) or Spinal Cord Injury (SCI)] are among the most costly health problems to society in industrialized countries. For those affected, they generate severe restrictions in mobility, significantly altering their quality of life.

Deterioration in motor function after stroke or BM is closely linked to the level of force produced at joint level. This is influenced by adaptations (neurological and tissue) inherent to the pathophysiology of the injury, and characterized by the presence of a spastic paresis syndrome.

Read more

A great deal of effort is devoted to motor neurorehabilitation (particularly physiotherapy) in the days and weeks following neurological injury. This so-called sub-acute rehabilitation phase is designed to have a positive impact on the patient's motor recovery (to prevent the development of spastic paresis), and to prevent future severe limitations in the long term.

Disorders observed in the chronic phase (partial recovery of strength, severe orthopedic deformities) demonstrate the limits of current therapies. In view of the results obtained in healthy subjects, eccentric training now seems to be one of the most promising physiotherapy methods for recovering muscle strength and countering neurological disorders.

However, its use in the sub-acute rehabilitation phase has never been evaluated in post-stroke or post-BM patients, either in terms of its effects on the strength developed in the strengthened muscles, or more locally on the neurological and tissue disorders found in these patients in the context of spastic paresis.

The aim of this project is to evaluate the effects of an eccentric muscle-strengthening exercise protocol on neurological patients in the sub-acute phase of their neurological impairment. The protocol will be applied to the ankle joint, given its importance for walking and the significant deficits found at this level in neurological populations.We hypothesize that the strengthening protocol will improve muscle strength at the ankle, and generate beneficial adaptations to combat the spastic paresis syndrome (improved muscle activation, increased muscle length, muscle volume, etc.).

Being tested
muscle-strengthening program
Keywords
Neurological rehabilitation, Physiotherapy, Eccentric muscle strengthening, Strength, Spastic paresis, Stroke, Spinal cord injury
Medical subject headings
Stroke, Spinal Cord Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • muscle-strengthening programOther

    a muscle-strengthening program applied to the ankle muscles (triceps surae and dorsal flexors) in physiotherapy, as a complement to conventional rehabilitation

Study groups in NCT06099340
Study groupRoleWhat they receive
Experimental " EXC "Experimentaleccentric strengthening + conventional rehabilitation
Receives: Other: muscle-strengthening program
Comparator " CONC "Active comparatorconcentric strengthening + conventional rehabilitation
Receives: Other: muscle-strengthening program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maximum joint force moment

    The force-generating capacity of the plantar flexors will be studied by measuring the maximum joint force moment on an isokinetic ergometer

    Measured: 10 weeks after the start of the muscle-strengthening protocol

Secondary outcomes (2)
  1. Measurement of joint force moment

    Measurement of joint force moment, performed on an isokinetic ergometer, in isometric condition

    Measured: 14 weeks after the start of the muscle-strengthening protocol

  2. Measurement of joint force moment

    Measurement of joint force moment, performed on an isokinetic ergometer, in isometric condition

    Measured: 10 weeks after the start of the muscle-strengthening protocol

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Oct 2023
  2. Study startSep 2024 (estimated)
  3. Primary completionOct 2027 (estimated)
  4. Study completionOct 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06099340
Sponsor's protocol ID
RC22_0475
Acronym
RenfExc
Status last verified
Aug 2024
First submitted
9 Oct 2023
Last updated
16 Aug 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing muscle-strengthening program in people with Spinal Cord Injured and Post-stroke, run by Nantes University Hospital at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 16 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Raphael Gross, PU-PH (02.40.84.62.08, raphael.gross@chu-nantes.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maximum joint force moment (time frame: 10 weeks after the start of the muscle-strengthening protocol). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in